Ixekizumab shows efficacy in children with enthesitis-related and juvenile psoriatic arthritis
New drug ixekizumab shows promise for children with arthritis
This multicentre, open-label, phase 3 study evaluated ixekizumab in 101 children with enthesitis-related arthritis or juvenile psoriatic art…
A phase 3 study found ixekizumab helped many children with arthritis meet response criteria at week 16, with mostly mild side effects report…
Network meta-analysis finds biologics superior to placebo for pediatric plaque psoriasis
Biologic treatments help children with moderate to severe psoriasis, analysis finds.
A network meta-analysis of randomized controlled trials including 1,016 pediatric psoriasis patients found all biologic therapies significan…
Biologic medicines help children with moderate to severe psoriasis achieve clear skin and better quality of life, analysis finds.